The European Patent Office (EPO) has granted patent EP3752608B1, titled 'Gene therapy of the FAAH pseudogene,' to inventors James John Cox and Devjit Srivastava. The patent was officially granted on March 18, 2026, and is designated for a number of European states including Germany, France, and the United Kingdom.

This grant represents the finalization of the patent process for this specific gene therapy. Companies operating in the biotechnology and pharmaceutical sectors, particularly those involved in gene therapy research and development, should note this patent's existence. While this is a grant of intellectual property and not a regulatory mandate, it may impact freedom to operate in related research areas.